Cholera vaccines
| Product Overview | |
| Generic Name | Cholera vaccines |
| Brand Name(s) | Dukoral, Shanchol, Euvichol, Euvichol-Plus, Euvichol-S (inactivated, oral) / Vaxchora live attenuated, oral |
| Form | Oral suspension |
| Strength | 3mL & 1.5mL dose |
| Therapeutic Class | Immunization—cholera prophylaxis |
| ATC Code | J07AE1-2 |
| Manufacturing & Regulatory | |
| Manufacturer | GCBC Vaccines Pvt. Ltd & EuBiologics Co., Ltd. |
| Country | India, Korea |
| GMP Compliance | WHO-GMP |
| Free Sale Certificate | manufacturer/MAH-dependent and not universally available for all destinations |
| Logistics & Export | |
| MOQ | 500 |
| Shelf Life | 24 months at 2–8°C |
| Storage | Cold chain 2–8°C; do not freeze |
| Incoterms | ExWorks- |
| Lead Time | Per allocation & production slot only |
| Documentation | |
| Certificate of Analysis (COA) | Yes—standard for vaccines: batch CoA/lot release documentation |
| SDS | manufacturer/distributor dependent |
| CTD Summary | Full CTD dossier proprietary; available under commercial agreement/license |
Description
Indicated for active immunization to reduce risk of cholera caused by Vibrio cholerae (primarily O1; some OCVs include O139). Used for travelers to cholera-affected areas and for outbreak control / endemic settings depending on product and national policy
